| Literature DB >> 34235132 |
Fang Zhang1, Shu-Ting He1, Yan Zhang1, Dong-Liang Mu1, Dong-Xin Wang1.
Abstract
Background: The present study was designed to investigate the relationship between two malnutrition assessment scales, perioperative nutrition screen (PONS) and Nutritional Risk Screening 2002 (NRS2002), with postoperative complications in elderly patients after noncardiac surgery.Entities:
Keywords: Nutritional Risk Screening 2002 (NRS2002); elderly patient; malnutrition; perioperative nutrition screen (PONS); postoperative complications
Year: 2021 PMID: 34235132 PMCID: PMC8255481 DOI: 10.3389/fpubh.2021.694368
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Frequency and definitions of major postoperative complications.
| 419 (45.8%) | |
| Delirium | 386 (42.1%) |
| Stroke | 6 (0.7%) |
| Myocardial infarction | 20 (2.2%) |
| New-onset arrhythmia | 25 (2.7) |
| Cardiac failure | 20 (2.2%) |
| Pulmonary embolism | 1 (0.1%) |
| Pneumonia | 13 (1.4%) |
| Respiratory failure | 16 (1.7%) |
| Acute kidney injury | 26 (2.8%) |
| Intestinal obstruction | 3 (0.3%) |
| Anastomotic fistula | 11 (1.2%) |
| Unexpected surgical bleeding | 3 (0.3%) |
| Gastrointestinal bleeding | 7 (0.8%) |
| Sepsis | 9 (1.0%) |
| Abdominal abscess | 7 (0.8%) |
| Incision infection | 16 (1.7%) |
| 13 (1.4%) | |
Delirium was established when the patient suffered any episode of delirium after surgery. According to onset time, it is divided into emergence delirium [from anesthesia emergency to discharge of post-anesthesia care unit (PACU)] and postoperative delirium (from discharge of PACU to postoperative 5 days). Emergence delirium happened in 282 (30.8%) patients and postoperative delirium in 47 (5.1%). A total of 57 (6.2%) patients suffered both emergence and postoperative delirium.
Confirmed by imaging examination and diagnosed by a neurologist.
Cardiac troponin I concentration met the criteria for clinical diagnosis, or ECG showed new emerging Q-waves lasting longer than 0.003 s, or ST-T changes lasting longer than 4 days.
Confirmed by ECG and needed medical treatment, i.e., medicine or electrical cardioversion.
Requiring the use of inotropic agents and/or vasopressors ≥ 24 h to maintain hemostasis.
Diagnosed by clinical presentation and/or imaging examination, i.e., CT or angiography.
New-onset infiltration on chest radiographs, body temperature ≥ 38°C, and white blood cell (WBC) elevated.
Respiratory failure was defined as mechanical ventilation ≥ 24 h.
Serum creatinine increased 1.5–1.9 times baseline or >0.3 mg/dl.
Confirmed by clinical symptoms, imaging examinations, or surgery.
Systemic inflammatory response involved two or more than two systems, existed in at least one organ system dysfunction, or required the use of vasopressors to maintain hemostasis.
Diagnosed by clinical symptoms or positive bacteria culture.
Figure 1Flowchart of the study.
Baseline characteristics.
| Age, year, mean ± SD | 71.6 ± 5.2 | 70.7 ± 4.6 | 72.7 ± 5.7 | <0.001 |
| ≥75 years old, | 264 (28.9%) | 109 (22.0%) | 155 (37%) | <0.001 |
| Male, | 548 (59.9%) | 309 (62.3%) | 239 (57.0%) | 0.106 |
| BMI, kg/m2, mean ± SD | 24.2 ± 3.5 | 24.2 ± 3.4 | 24.1 ± 3.6 | 0.783 |
| Stroke | 52 (5.7%) | 28 (5.6%) | 24 (5.7%) | 0.957 |
| Hypertension | 475 (51.9%) | 252 (50.8%) | 223 (53.2%) | 0.466 |
| Coronary heart disease | 129 (14.1%) | 58 (11.6%) | 71 (16.9%) | 0.023 |
| Arrhythmia | 57 (6.2%) | 24 (4.8%) | 33 (7.9%) | 0.058 |
| Pulmonary disease | 66 (7.2%) | 27 (5.4%) | 39 (9.3%) | 0.024 |
| Diabetes | 219 (23.9%) | 112 (22.6%) | 107 (25.5%) | 0.296 |
| Hyperlipidemia | 95 (10.4%) | 48 (9.6%) | 47 (11.2%) | 0.447 |
| Hepatic dysfunction, | 45 (4.9%) | 19 (3.8%) | 26 (6.2%) | 0.098 |
| Malignant tumor, | 105 (11.5%) | 53 (10.7%) | 52 (12.4%) | 0.415 |
| Chronic smoking, | 223 (24.4%) | 128 (25.8%) | 95 (22.7%) | 0.271 |
| CCI, median (IQR) | 2 (2, 3) | 2 (2, 3) | 2 (2, 3) | 0.102 |
| Mild cognitive dysfunction, | 597 (65.2%) | 286 (57.7%) | 311 (74.2%) | <0.001 |
| PONS, median (IQR) | 0 (0, 1) | 0 (0, 0) | 0 (0, 1) | <0.001 |
| PONS ≥ 1, | 250 (27.3%) | 90 (18.1%) | 160 (38.2%) | <0.001 |
| NRS2002, median (IQR) | 3 (2, 4) | 2 (2, 3) | 3 (2, 4) | <0.001 |
| NRS2002 ≥ 3, | 490 (53.6%) | 235 (47.4%) | 255 (60.9%) | <0.001 |
| II | 678 (74.0%) | 395 (79.6%) | 283 (67.5%) | |
| III | 237 (26.0%) | 101 (20.4%) | 136 (32.5%) | |
| Albumin (g/L) | 40.6 ± 4.7 | 41.0 ± 4.7 | 40.0 ± 4.6 | 0.001 |
| <30 g/L, | 22 (2.4%) | 12 (2.4%) | 10 (2.4%) | 0.974 |
| Creatinine (μmol/L) | 80.2 ± 20.9 | 79.5 ± 19.9 | 81.0 ± 22.0 | 0.300 |
| Glucose, mmol/L, mean ± SD | 6.0 ± 1.7 | 6.0 ± 1.6 | 6.0 ± 1.9 | 0.832 |
SD, standard deviation; BMI, body mass index; CCI, Charlson Comorbidity Index; PONS, perioperative nutrition screen; IQR, interquartile range; NRS2002, Nutritional Risk Screening 2002; ASA, American Society of Anesthesiology.
Pulmonary disease included chronic obstructive pulmonary disease and asthma.
Hepatic dysfunction was defined as alanine transaminase and/or aspartate transaminase higher than five times the upper normal limit.
Malignant tumor was defined as carcinoma (carcinoma, squamous cell carcinoma, and adenocarcinoma), sarcoma, and undifferentiated carcinoma.
Chronic smoking was defined as half a pack of cigarettes per day for at least 2 years.
Mild cognitive dysfunction was defined as Montreal cognitive assessment score <27.
Perioperative variables.
| Type of anesthesia, | 0.262 | |||
| General anesthesia | 420 (45.9%) | 229 (46.2%) | 191 (45.6%) | |
| General-PNB anesthesia | 469 (51.3%) | 257 (51.8%) | 212 (50.6%) | |
| Epidural-general | 26 (2.8%) | 10 (2.0%) | 16 (3.8%) | |
| Use of nitrous oxide, | 553 (60.4%) | 299 (60.3%) | 254 (60.6%) | 0.917 |
| Use of sevoflurane, | 287 (31.4%) | 150 (30.2%) | 137 (32.7%) | 0.425 |
| Use of dexmedetomidine, | 430 (47.0%) | 232 (46.8%) | 198 (47.3%) | 0.884 |
| Use of midazolam, | 189 (20.7%) | 105 (21.2%) | 84 (20.0%) | 0.676 |
| Use of etomidate, | 699 (76.4%) | 367 (74.0%) | 332 (79.2%) | 0.063 |
| Propofol (mg) median (IQR) | 840 (642, 1,075) | 800 (620, 1,040) | 875 (680, 1,132) | <0.001 |
| Sufentanil equivalent (μg) | 110 (77, 160) | 109 (75, 158) | 80 (112, 165) | 0.162 |
| Surgery time (h), mead ± SD | 3.4 ± 1.2 | 3.3 ± 1.1 | 3.5 ± 1.2 | 0.001 |
| Location of surgery, | 0.296 | |||
| Intra-thoracic | 198 (21.6%) | 114 (23.0%) | 84 (20.0%) | |
| Intra-abdominal | 530 (57.9%) | 289 (58.3%) | 241 (57.5%) | |
| Spinal/extremities/others | 187 (20.4%) | 93 (18.8%) | 94 (22.4%) | |
| Estimated blood loss, ml, median (IQR) | 100 (10, 250) | 50 (10, 200) | 100 (10, 300) | <0.001 |
| Allogeneic blood transfusion, | 79 (8.6%) | 27 (5.4%) | 52 (12.4%) | <0.001 |
| Total fluid infusion (ml), median (IQR) | 2,200 (1,600, 2,850) | 2,100 (1,600, 2,600) | 2,350 (1,750, 3,100) | <0.001 |
| Urine output (ml), median (IQR) | 400 (250, 600) | 250 (400, 600) | 350 (200, 600) | 0.632 |
| Use of parenteral nutrition, | 343 (37.5%) | 168 (33.9%) | 175 (41.8%) | 0.016 |
| Postoperative LOS, days, median (IQR) | 8 (6, 11) | 7 (5, 9) | 9 (6, 12) | <0.001 |
PNB, peripheral nerve block; SD, standard deviation; IQR, interquartile range; LOS, length of in-hospital stay.
Combined general-PNB anesthesia indicated that patients received both general anesthesia and peripheral nerve block (including epidural anesthesia).
Intraoperative opioids included remifentanil and sufentanil. The dosage of remifentanil was converted into equivalent of sufentanil according to the following formula: dosage of sufentanil (μg) = the dosage of remifentanil (μg)/10.
The relationship between PONS and postoperative complications.
| Age (per year increase) | 1.076 | 1.048–1.104 | <0.001 | 1.059 | 1.029–1.089 | <0.001 | 1.055 | 1.024–1.087 | <0.001 |
| Coronary heart disease (yes) | 1.541 | 1.060–2.240 | 0.024 | — | — | — | 1.149 | 0.754–1.752 | 0.519 |
| Pulmonary disease (yes) | 2.043 | 1.220–3.422 | 0.007 | 2.088 | 1.205–3.619 | 0.009 | — | — | — |
| Mild cognitive dysfunction | 2.114 | 1.595–2.804 | <0.001 | 2.100 | 1.557–2.833 | <0.001 | 2.083 | 1.553–2.794 | <0.001 |
| ASA classification (per grade increase) | 1.879 | 1.393–2.535 | <0.001 | 1.399 | 1.009–1.939 | 0.044 | 1.523 | 1.108–2.092 | 0.009 |
| NRS2002 score ≥ 3 | 1.727 | 1.327–2.248 | <0.001 | NA | NA | NA | 1.313 | 0.973–1.771 | 0.075 |
| PONS score ≥ 1 | 2.787 | 2.061–3.768 | <0.001 | 2.308 | 1.676–3.178 | <0.001 | NA | NA | NA |
| Duration of surgery (per hour increase) | 1.203 | 1.074–1.348 | 0.001 | 1.149 | 1.014–1.302 | 0.029 | 1.212 | 1.073–1.369 | 0.002 |
| Allogeneic blood transfusion (yes) | 2.461 | 1.516–3.996 | <0.001 | 2.119 | 1.259–3.567 | 0.005 | 2.091 | 1.250–3.497 | 0.005 |
ASA, American Society of Anesthesiologists; NRS2002, Nutritional Risk Screening 2002; PONS, perioperative nutrition screen; OR, odds ratio; CI, confidence interval; NA, not available.
PONS ≥ 1 and NRS2002 ≥ 3 were put into the multivariate analysis separately.
Pulmonary disease was defined as chronic obstructive pulmonary disease and asthma.
Mild cognitive impairment was defined as Mini-Mental State Examination (MMSE) score <27.
Figure 2Receiver operating characteristic (ROC) analysis. ROC curve analysis showed that the performances of PONS and NRS2002 were poor in predicting postoperative complications. PONS, perioperative nutrition screen; NRS2002, Nutritional Risk Screening 2002; AUC, area under curve; CI, confidence interval.